In January 2022, the European Commission (EC), the Heads of Medicines Agencies (HMA), and the European Medicines Agency (EMA) launched the Accelerating Clinical Trials in the EU (ACT EU) initiative. This initiative consists of ten suggested actions for sites, sponsors, and clinical research organizations (CROs) to take over the next three years, leading up to the full implementation deadline in January 2025. The goal of ACT EU is to facilitate the implementation of the EU CTR and CTIS and accelerate clinical trials in the EU. This blog will explore the implications of the EU CTR on staffing requirements and how organizations can prepare for and navigate the changes.

Optimize Your Clinical Trial Team

Consult Us Now

Impact of the EU CTR on Staffing Requirements

The EU CTR has several implications for staffing requirements in the context of clinical trial management. Some of the key areas affected include:

1. Regulatory Affairs and Compliance

The new regulation necessitates a comprehensive understanding of its requirements, leading to an increased demand for regulatory affairs professionals. Organizations will need experts who can interpret the regulations, ensure compliance, and coordinate with regulatory authorities.

2. Clinical Operations

The EU CTR's emphasis on transparency and information sharing requires skilled professionals to manage the operational aspects of clinical trials. This includes roles such as Clinical Research Associates (CRAs) and Clinical Trial Managers who are well-versed in the new requirements.

3. Language and Translation

The EU CTR mandates that all documents related to a clinical trial must be translated into the language(s) of the trial participants. This requirement increases the need for language experts and translators to ensure compliance with the regulation.

Staffing Strategies for EU CTR Compliance

To address the staffing requirements imposed by the EU CTR, organizations can consider the following strategies:

• Training and Education

Investing in training and educational resources for existing staff and new hires is essential to ensure that personnel are well-prepared to navigate the complexities of the new regulation.

• Collaboration and Coordination

Effective collaboration between regulatory affairs, clinical operations, and translation teams is crucial for successful compliance with the EU CTR. Organizations should focus on integrating these functions to streamline processes and ensure accuracy.

• Talent Acquisition

Given the increased demand for regulatory and clinical operations expertise, organizations may need to expand their talent pool by recruiting professionals with specific experience in EU regulatory requirements and clinical trial management.

Sponsors of clinical trials are ultimately responsible for ensuring that all personnel involved in their trials are qualified and competent. This includes:

• Developing a plan for staffing the trial: This plan should identify the roles required, the qualifications and experience needed for each role, and the process for selecting and onboarding personnel.
• Implementing a system for training and development: This system should ensure that all personnel receive the necessary training to perform their assigned tasks effectively.
• Monitoring the performance of personnel: This process helps to identify any gaps in knowledge or skills and ensure that personnel is meeting their responsibilities.

Conclusion

The CTR's staffing requirements are vital for ensuring the quality and safety of clinical trials conducted in the EU. By partnering with a seasoned expert like Freyr, who can help in planning, implementing, and monitoring staffing arrangements, and by doing so sponsors can ensure their trials are conducted to the highest standards and contribute to the development of safe and effective new medicines.